Andrew H Limper

10PUBLICATIONS
12CO-AUTHORS
Medical infection agents (incl. prions)Medical mycologyPharmacogenomicsImmunogenetics (incl. genetic immunology)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 24, 2026
The tyrosine kinase receptor EphA2 in alveolar macrophages provides a protective role in host defense against Pneumocystis pneumonia.

|Nov 20, 2025
Global prevalence of multidrug-resistant Candida auris in humans between 2015 and 2024: A systematic review and meta-analysis.

Conrad C Achilonu, Will J Barwatt, Theodore J Kottom

|Jul 16, 2025
The Maximum-Tolerated Dose and Pharmacokinetics of ISFP10 a Novel Inhibitor of Fungal Phosphoglucomutase (PGM).

Theodore J Kottom, Andrew H Limper

|Jan 02, 2025
The importance of Fcγ and C-type lectin receptors in host immune responses during <i>Pneumocystis</i> pneumonia.

Theodore J Kottom, Eva M Carmona, Kyle Schaefbauer

|Jan 23, 2024
Characterization of the <i>Pneumocystis jirovecii</i> and <i>Pneumocystis murina</i> phosphoglucomutases (Pgm2s): a potential target for <i>Pneumocystis</i> therapy.

Theodore J Kottom, Eva M Carmona, Andrew H Limper

|Jan 11, 2024
Targeting host tyrosine kinase receptor EphA2 signaling via small-molecule ALW-II-41-27 inhibits macrophage pro-inflammatory signaling responses to <i>Pneumocystis carinii</i> β-glucans.

Theodore J Kottom, Eva M Carmona, Andrew H Limper

Pageof 2

Frequent Collaborators

5 joint publications

Theodore J Kottom

2 joint publications

Jason N Barreto

2 joint publications

Carrie A Thompson

2 joint publications

Kristin C Mara